FFCP PHASE2:Hg19::chr10:105670710..105670720,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr10:105670710..105670720, - |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr10:105670710..105670720, - |
| Coexpression cluster: | C7_CD14_Eosinophils_Neutrophils_Smooth_Basophils_Macrophage_Mast |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr10:105670710..105670720- |
|---|
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| classical monocyte | 4.81e-17 | 42 |
| CD14-positive, CD16-negative classical monocyte | 4.81e-17 | 42 |
| defensive cell | 6.52e-15 | 48 |
| phagocyte | 6.52e-15 | 48 |
| myeloid leukocyte | 3.78e-13 | 72 |
| monopoietic cell | 6.41e-12 | 59 |
| monocyte | 6.41e-12 | 59 |
| monoblast | 6.41e-12 | 59 |
| promonocyte | 6.41e-12 | 59 |
| macrophage dendritic cell progenitor | 1.56e-11 | 61 |
Showing 1 to 10 of 16 entries
| Ontology term | p-value | n |
|---|---|---|
| bone marrow | 2.89e-09 | 76 |
| bone element | 1.38e-08 | 82 |
| skeletal element | 8.12e-08 | 90 |
| immune system | 1.46e-07 | 93 |
| hematopoietic system | 3.59e-07 | 98 |
| blood island | 3.59e-07 | 98 |
| skeletal system | 5.02e-07 | 100 |
Showing 1 to 7 of 7 entries
